However, the role of TGF-β signaling in AD pathogenesis has been conflicting, whereby some studies have reported that TGF-β1 administration can restore synaptic plasticity and alleviate neurodegeneration [28, 29]. Here, TGFB1 is linked to Alzheimer disease.